Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bufei Huatan refers to a category of Traditional Chinese Medicine (TCM) formulas designed to "tonify the lung" (Bufei) and "resolve phlegm" (Huatan). These multi-ingredient herbal preparations are traditionally used to address various respiratory conditions characterized by lung qi deficiency and excessive phlegm accumulation. While not a single standardized formula, specific "Bufei" and "Huatan" related formulas have been investigated for their potential therapeutic effects in conditions such as chronic obstructive pulmonary disease (COPD), bronchial asthma, and as an adjuvant therapy for lung cancer and convalescent COVID-19. Their mechanisms often involve anti-inflammatory, immunomodulatory, and mucolytic actions, aiming to improve lung function, reduce exacerbations, and alleviate symptoms like cough, shortness of breath, and fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bufei Huatan.